nodes	percent_of_prediction	percent_of_DWPC	metapath
Vandetanib—FGR—myometrium—uterine fibroid	0.0039	0.00559	CbGeAlD
Vandetanib—PTK6—vagina—uterine fibroid	0.0039	0.00559	CbGeAlD
Vandetanib—AXL—myometrium—uterine fibroid	0.00388	0.00556	CbGeAlD
Vandetanib—YES1—nipple—uterine fibroid	0.00382	0.00548	CbGeAlD
Vandetanib—SLK—myometrium—uterine fibroid	0.00374	0.00536	CbGeAlD
Vandetanib—FYN—myometrium—uterine fibroid	0.00364	0.00521	CbGeAlD
Vandetanib—BMPR1B—uterus—uterine fibroid	0.00363	0.00521	CbGeAlD
Vandetanib—EPHA6—female reproductive system—uterine fibroid	0.0036	0.00515	CbGeAlD
Vandetanib—MAP4K5—myometrium—uterine fibroid	0.00355	0.00509	CbGeAlD
Vandetanib—PLK4—female reproductive system—uterine fibroid	0.00355	0.00509	CbGeAlD
Vandetanib—EGFR—uterine cervix—uterine fibroid	0.00353	0.00505	CbGeAlD
Vandetanib—RIPK2—uterine cervix—uterine fibroid	0.00342	0.0049	CbGeAlD
Vandetanib—VEGFA—uterine cervix—uterine fibroid	0.00341	0.00488	CbGeAlD
Vandetanib—EPHB6—myometrium—uterine fibroid	0.0034	0.00486	CbGeAlD
Vandetanib—FMO1—uterine cervix—uterine fibroid	0.00339	0.00486	CbGeAlD
Vandetanib—MAP2K5—nipple—uterine fibroid	0.00338	0.00485	CbGeAlD
Vandetanib—KDR—nipple—uterine fibroid	0.00338	0.00485	CbGeAlD
Vandetanib—IRAK4—uterine cervix—uterine fibroid	0.00334	0.00478	CbGeAlD
Vandetanib—TYRO3—female reproductive system—uterine fibroid	0.00334	0.00478	CbGeAlD
Vandetanib—VEGFA—smooth muscle tissue—uterine fibroid	0.00331	0.00475	CbGeAlD
Vandetanib—YES1—myometrium—uterine fibroid	0.00328	0.0047	CbGeAlD
Vandetanib—FLT4—decidua—uterine fibroid	0.00328	0.00469	CbGeAlD
Vandetanib—ERBB3—uterine cervix—uterine fibroid	0.00327	0.00469	CbGeAlD
Vandetanib—BMPR1B—female reproductive system—uterine fibroid	0.00327	0.00468	CbGeAlD
Vandetanib—MAP3K19—female reproductive system—uterine fibroid	0.00327	0.00468	CbGeAlD
Vandetanib—RIPK2—decidua—uterine fibroid	0.00326	0.00467	CbGeAlD
Vandetanib—STK10—myometrium—uterine fibroid	0.00325	0.00466	CbGeAlD
Vandetanib—VEGFA—decidua—uterine fibroid	0.00325	0.00465	CbGeAlD
Vandetanib—IRAK4—decidua—uterine fibroid	0.00318	0.00456	CbGeAlD
Vandetanib—RIPK2—urethra—uterine fibroid	0.00314	0.0045	CbGeAlD
Vandetanib—VEGFA—urethra—uterine fibroid	0.00313	0.00449	CbGeAlD
Vandetanib—FMO1—urethra—uterine fibroid	0.00312	0.00446	CbGeAlD
Vandetanib—STK35—cardiac atrium—uterine fibroid	0.00311	0.00445	CbGeAlD
Vandetanib—RIPK2—endometrium—uterine fibroid	0.00309	0.00443	CbGeAlD
Vandetanib—EGFR—mammalian vulva—uterine fibroid	0.00309	0.00442	CbGeAlD
Vandetanib—VEGFA—endometrium—uterine fibroid	0.00308	0.00442	CbGeAlD
Vandetanib—MKNK1—uterine cervix—uterine fibroid	0.00307	0.0044	CbGeAlD
Vandetanib—IRAK4—urethra—uterine fibroid	0.00307	0.0044	CbGeAlD
Vandetanib—FMO1—endometrium—uterine fibroid	0.00307	0.00439	CbGeAlD
Vandetanib—LCK—uterine cervix—uterine fibroid	0.00303	0.00435	CbGeAlD
Vandetanib—TYRO3—female gonad—uterine fibroid	0.00303	0.00435	CbGeAlD
Vandetanib—AXL—uterine cervix—uterine fibroid	0.00302	0.00433	CbGeAlD
Vandetanib—IRAK4—endometrium—uterine fibroid	0.00302	0.00433	CbGeAlD
Vandetanib—EPHA5—vagina—uterine fibroid	0.00302	0.00432	CbGeAlD
Vandetanib—VEGFA—mammalian vulva—uterine fibroid	0.00298	0.00427	CbGeAlD
Vandetanib—BMPR1B—female gonad—uterine fibroid	0.00297	0.00426	CbGeAlD
Vandetanib—FMO1—mammalian vulva—uterine fibroid	0.00297	0.00425	CbGeAlD
Vandetanib—EGFR—uterus—uterine fibroid	0.00294	0.00421	CbGeAlD
Vandetanib—AXL—smooth muscle tissue—uterine fibroid	0.00294	0.00421	CbGeAlD
Vandetanib—PDGFRB—nipple—uterine fibroid	0.00293	0.0042	CbGeAlD
Vandetanib—MKNK1—decidua—uterine fibroid	0.00293	0.00419	CbGeAlD
Vandetanib—IRAK4—mammalian vulva—uterine fibroid	0.00292	0.00418	CbGeAlD
Vandetanib—SLK—uterine cervix—uterine fibroid	0.00291	0.00417	CbGeAlD
Vandetanib—KDR—myometrium—uterine fibroid	0.0029	0.00416	CbGeAlD
Vandetanib—MAP2K5—myometrium—uterine fibroid	0.0029	0.00416	CbGeAlD
Vandetanib—RET—decidua—uterine fibroid	0.00289	0.00414	CbGeAlD
Vandetanib—FGR—decidua—uterine fibroid	0.00289	0.00414	CbGeAlD
Vandetanib—LCK—decidua—uterine fibroid	0.00289	0.00414	CbGeAlD
Vandetanib—AXL—decidua—uterine fibroid	0.00288	0.00413	CbGeAlD
Vandetanib—RIPK2—cardiac atrium—uterine fibroid	0.00286	0.0041	CbGeAlD
Vandetanib—VEGFA—cardiac atrium—uterine fibroid	0.00286	0.00409	CbGeAlD
Vandetanib—VEGFA—uterus—uterine fibroid	0.00284	0.00407	CbGeAlD
Vandetanib—FLT3—female reproductive system—uterine fibroid	0.00284	0.00406	CbGeAlD
Vandetanib—FYN—uterine cervix—uterine fibroid	0.00283	0.00405	CbGeAlD
Vandetanib—MKNK1—urethra—uterine fibroid	0.00282	0.00404	CbGeAlD
Vandetanib—LCK—urethra—uterine fibroid	0.00279	0.004	CbGeAlD
Vandetanib—FGR—urethra—uterine fibroid	0.00279	0.004	CbGeAlD
Vandetanib—MKNK1—endometrium—uterine fibroid	0.00278	0.00398	CbGeAlD
Vandetanib—STK35—female reproductive system—uterine fibroid	0.00278	0.00398	CbGeAlD
Vandetanib—AXL—urethra—uterine fibroid	0.00278	0.00398	CbGeAlD
Vandetanib—SLK—decidua—uterine fibroid	0.00277	0.00397	CbGeAlD
Vandetanib—MAP4K5—uterine cervix—uterine fibroid	0.00276	0.00396	CbGeAlD
Vandetanib—FYN—smooth muscle tissue—uterine fibroid	0.00275	0.00394	CbGeAlD
Vandetanib—FGR—endometrium—uterine fibroid	0.00274	0.00393	CbGeAlD
Vandetanib—AXL—endometrium—uterine fibroid	0.00273	0.00392	CbGeAlD
Vandetanib—ERBB3—uterus—uterine fibroid	0.00273	0.00391	CbGeAlD
Vandetanib—FYN—decidua—uterine fibroid	0.0027	0.00386	CbGeAlD
Vandetanib—MKNK1—mammalian vulva—uterine fibroid	0.00269	0.00385	CbGeAlD
Vandetanib—TEK—smooth muscle tissue—uterine fibroid	0.00269	0.00385	CbGeAlD
Vandetanib—MAP4K5—smooth muscle tissue—uterine fibroid	0.00269	0.00385	CbGeAlD
Vandetanib—SLK—urethra—uterine fibroid	0.00267	0.00383	CbGeAlD
Vandetanib—LCK—mammalian vulva—uterine fibroid	0.00266	0.0038	CbGeAlD
Vandetanib—FGR—mammalian vulva—uterine fibroid	0.00266	0.0038	CbGeAlD
Vandetanib—AXL—mammalian vulva—uterine fibroid	0.00264	0.00379	CbGeAlD
Vandetanib—EPHB6—uterine cervix—uterine fibroid	0.00264	0.00378	CbGeAlD
Vandetanib—MAP4K5—decidua—uterine fibroid	0.00263	0.00377	CbGeAlD
Vandetanib—TEK—decidua—uterine fibroid	0.00263	0.00377	CbGeAlD
Vandetanib—SLK—endometrium—uterine fibroid	0.00263	0.00377	CbGeAlD
Vandetanib—ABL1—nipple—uterine fibroid	0.00261	0.00374	CbGeAlD
Vandetanib—FYN—urethra—uterine fibroid	0.0026	0.00372	CbGeAlD
Vandetanib—FLT3—female gonad—uterine fibroid	0.00258	0.0037	CbGeAlD
Vandetanib—FLT4—female reproductive system—uterine fibroid	0.00258	0.00369	CbGeAlD
Vandetanib—MKNK1—cardiac atrium—uterine fibroid	0.00257	0.00369	CbGeAlD
Vandetanib—FMO3—mammalian vulva—uterine fibroid	0.00256	0.00367	CbGeAlD
Vandetanib—RIPK2—female reproductive system—uterine fibroid	0.00256	0.00367	CbGeAlD
Vandetanib—FYN—endometrium—uterine fibroid	0.00256	0.00367	CbGeAlD
Vandetanib—YES1—uterine cervix—uterine fibroid	0.00255	0.00366	CbGeAlD
Vandetanib—SLK—mammalian vulva—uterine fibroid	0.00255	0.00365	CbGeAlD
Vandetanib—MAP4K5—urethra—uterine fibroid	0.00254	0.00364	CbGeAlD
Vandetanib—TEK—urethra—uterine fibroid	0.00254	0.00364	CbGeAlD
Vandetanib—AXL—cardiac atrium—uterine fibroid	0.00253	0.00363	CbGeAlD
Vandetanib—STK10—uterine cervix—uterine fibroid	0.00253	0.00362	CbGeAlD
Vandetanib—LCK—uterus—uterine fibroid	0.00253	0.00362	CbGeAlD
Vandetanib—STK35—female gonad—uterine fibroid	0.00253	0.00362	CbGeAlD
Vandetanib—AXL—uterus—uterine fibroid	0.00252	0.00361	CbGeAlD
Vandetanib—EPHB6—decidua—uterine fibroid	0.00252	0.00361	CbGeAlD
Vandetanib—PDGFRB—myometrium—uterine fibroid	0.00251	0.0036	CbGeAlD
Vandetanib—STK35—vagina—uterine fibroid	0.00251	0.0036	CbGeAlD
Vandetanib—TEK—endometrium—uterine fibroid	0.0025	0.00358	CbGeAlD
Vandetanib—MAP4K5—endometrium—uterine fibroid	0.0025	0.00358	CbGeAlD
Vandetanib—YES1—smooth muscle tissue—uterine fibroid	0.00248	0.00355	CbGeAlD
Vandetanib—FYN—mammalian vulva—uterine fibroid	0.00248	0.00355	CbGeAlD
Vandetanib—ABL2—female gonad—uterine fibroid	0.00246	0.00353	CbGeAlD
Vandetanib—SRC—uterine cervix—uterine fibroid	0.00246	0.00352	CbGeAlD
Vandetanib—ERBB3—female reproductive system—uterine fibroid	0.00245	0.00351	CbGeAlD
Vandetanib—ABL2—vagina—uterine fibroid	0.00245	0.00351	CbGeAlD
Vandetanib—SLK—cardiac atrium—uterine fibroid	0.00244	0.00349	CbGeAlD
Vandetanib—YES1—decidua—uterine fibroid	0.00243	0.00348	CbGeAlD
Vandetanib—EPHB6—urethra—uterine fibroid	0.00243	0.00348	CbGeAlD
Vandetanib—SLK—uterus—uterine fibroid	0.00243	0.00347	CbGeAlD
Vandetanib—MAP4K5—mammalian vulva—uterine fibroid	0.00242	0.00346	CbGeAlD
Vandetanib—STK10—decidua—uterine fibroid	0.00241	0.00345	CbGeAlD
Vandetanib—EGFR—female gonad—uterine fibroid	0.0024	0.00344	CbGeAlD
Vandetanib—EPHB6—endometrium—uterine fibroid	0.00239	0.00342	CbGeAlD
Vandetanib—SRC—smooth muscle tissue—uterine fibroid	0.00239	0.00342	CbGeAlD
Vandetanib—FYN—cardiac atrium—uterine fibroid	0.00237	0.0034	CbGeAlD
Vandetanib—FYN—uterus—uterine fibroid	0.00236	0.00338	CbGeAlD
Vandetanib—YES1—urethra—uterine fibroid	0.00235	0.00336	CbGeAlD
Vandetanib—FLT4—female gonad—uterine fibroid	0.00234	0.00336	CbGeAlD
Vandetanib—SRC—decidua—uterine fibroid	0.00234	0.00335	CbGeAlD
Vandetanib—RIPK2—female gonad—uterine fibroid	0.00233	0.00334	CbGeAlD
Vandetanib—VEGFA—female gonad—uterine fibroid	0.00232	0.00333	CbGeAlD
Vandetanib—RIPK2—vagina—uterine fibroid	0.00232	0.00332	CbGeAlD
Vandetanib—TEK—cardiac atrium—uterine fibroid	0.00232	0.00332	CbGeAlD
Vandetanib—MAP4K5—cardiac atrium—uterine fibroid	0.00232	0.00332	CbGeAlD
Vandetanib—FMO1—female gonad—uterine fibroid	0.00231	0.00331	CbGeAlD
Vandetanib—EPHB6—mammalian vulva—uterine fibroid	0.00231	0.00331	CbGeAlD
Vandetanib—VEGFA—vagina—uterine fibroid	0.00231	0.00331	CbGeAlD
Vandetanib—YES1—endometrium—uterine fibroid	0.00231	0.00331	CbGeAlD
Vandetanib—MAP4K5—uterus—uterine fibroid	0.0023	0.0033	CbGeAlD
Vandetanib—TEK—uterus—uterine fibroid	0.0023	0.0033	CbGeAlD
Vandetanib—MKNK1—female reproductive system—uterine fibroid	0.0023	0.0033	CbGeAlD
Vandetanib—FMO1—vagina—uterine fibroid	0.0023	0.00329	CbGeAlD
Vandetanib—IRAK4—female gonad—uterine fibroid	0.00228	0.00326	CbGeAlD
Vandetanib—FGR—female reproductive system—uterine fibroid	0.00227	0.00326	CbGeAlD
Vandetanib—AXL—female reproductive system—uterine fibroid	0.00226	0.00324	CbGeAlD
Vandetanib—IRAK4—vagina—uterine fibroid	0.00226	0.00324	CbGeAlD
Vandetanib—MAP2K5—uterine cervix—uterine fibroid	0.00226	0.00324	CbGeAlD
Vandetanib—KDR—uterine cervix—uterine fibroid	0.00226	0.00324	CbGeAlD
Vandetanib—ABL1—myometrium—uterine fibroid	0.00224	0.00321	CbGeAlD
Vandetanib—YES1—mammalian vulva—uterine fibroid	0.00223	0.0032	CbGeAlD
Vandetanib—ERBB3—female gonad—uterine fibroid	0.00223	0.0032	CbGeAlD
Vandetanib—STK10—mammalian vulva—uterine fibroid	0.00221	0.00317	CbGeAlD
Vandetanib—EPHB6—cardiac atrium—uterine fibroid	0.00221	0.00317	CbGeAlD
Vandetanib—KDR—smooth muscle tissue—uterine fibroid	0.0022	0.00315	CbGeAlD
Vandetanib—MAP2K5—decidua—uterine fibroid	0.00215	0.00308	CbGeAlD
Vandetanib—KDR—decidua—uterine fibroid	0.00215	0.00308	CbGeAlD
Vandetanib—YES1—cardiac atrium—uterine fibroid	0.00214	0.00306	CbGeAlD
Vandetanib—YES1—uterus—uterine fibroid	0.00213	0.00305	CbGeAlD
Vandetanib—FYN—female reproductive system—uterine fibroid	0.00212	0.00304	CbGeAlD
Vandetanib—STK10—uterus—uterine fibroid	0.00211	0.00302	CbGeAlD
Vandetanib—MKNK1—female gonad—uterine fibroid	0.00209	0.003	CbGeAlD
Vandetanib—MKNK1—vagina—uterine fibroid	0.00208	0.00298	CbGeAlD
Vandetanib—KDR—urethra—uterine fibroid	0.00208	0.00297	CbGeAlD
Vandetanib—MAP2K5—urethra—uterine fibroid	0.00208	0.00297	CbGeAlD
Vandetanib—TEK—female reproductive system—uterine fibroid	0.00207	0.00297	CbGeAlD
Vandetanib—MAP4K5—female reproductive system—uterine fibroid	0.00207	0.00297	CbGeAlD
Vandetanib—LCK—female gonad—uterine fibroid	0.00207	0.00296	CbGeAlD
Vandetanib—FGR—female gonad—uterine fibroid	0.00207	0.00296	CbGeAlD
Vandetanib—AXL—female gonad—uterine fibroid	0.00206	0.00295	CbGeAlD
Vandetanib—SRC—cardiac atrium—uterine fibroid	0.00206	0.00295	CbGeAlD
Vandetanib—FGR—vagina—uterine fibroid	0.00206	0.00295	CbGeAlD
Vandetanib—LCK—vagina—uterine fibroid	0.00206	0.00295	CbGeAlD
Vandetanib—AXL—vagina—uterine fibroid	0.00205	0.00293	CbGeAlD
Vandetanib—MAP2K5—endometrium—uterine fibroid	0.00204	0.00293	CbGeAlD
Vandetanib—KDR—endometrium—uterine fibroid	0.00204	0.00293	CbGeAlD
Vandetanib—ABCC1—nipple—uterine fibroid	0.00199	0.00285	CbGeAlD
Vandetanib—FMO3—vagina—uterine fibroid	0.00199	0.00285	CbGeAlD
Vandetanib—SLK—female gonad—uterine fibroid	0.00198	0.00284	CbGeAlD
Vandetanib—KDR—mammalian vulva—uterine fibroid	0.00198	0.00283	CbGeAlD
Vandetanib—MAP2K5—mammalian vulva—uterine fibroid	0.00198	0.00283	CbGeAlD
Vandetanib—SLK—vagina—uterine fibroid	0.00197	0.00282	CbGeAlD
Vandetanib—PDGFRB—uterine cervix—uterine fibroid	0.00196	0.0028	CbGeAlD
Vandetanib—FYN—female gonad—uterine fibroid	0.00193	0.00276	CbGeAlD
Vandetanib—FYN—vagina—uterine fibroid	0.00192	0.00275	CbGeAlD
Vandetanib—YES1—female reproductive system—uterine fibroid	0.00191	0.00274	CbGeAlD
Vandetanib—PDGFRB—smooth muscle tissue—uterine fibroid	0.0019	0.00272	CbGeAlD
Vandetanib—STK10—female reproductive system—uterine fibroid	0.0019	0.00272	CbGeAlD
Vandetanib—MAP2K5—cardiac atrium—uterine fibroid	0.00189	0.00271	CbGeAlD
Vandetanib—KDR—cardiac atrium—uterine fibroid	0.00189	0.00271	CbGeAlD
Vandetanib—MAP4K5—female gonad—uterine fibroid	0.00188	0.0027	CbGeAlD
Vandetanib—TEK—female gonad—uterine fibroid	0.00188	0.0027	CbGeAlD
Vandetanib—KDR—uterus—uterine fibroid	0.00188	0.0027	CbGeAlD
Vandetanib—MAP4K5—vagina—uterine fibroid	0.00187	0.00268	CbGeAlD
Vandetanib—PDGFRB—decidua—uterine fibroid	0.00186	0.00267	CbGeAlD
Vandetanib—SRC—female reproductive system—uterine fibroid	0.00184	0.00264	CbGeAlD
Vandetanib—EPHB6—female gonad—uterine fibroid	0.0018	0.00258	CbGeAlD
Vandetanib—PDGFRB—urethra—uterine fibroid	0.0018	0.00257	CbGeAlD
Vandetanib—EPHB6—vagina—uterine fibroid	0.00179	0.00256	CbGeAlD
Vandetanib—PDGFRB—endometrium—uterine fibroid	0.00177	0.00253	CbGeAlD
Vandetanib—ABL1—uterine cervix—uterine fibroid	0.00174	0.0025	CbGeAlD
Vandetanib—YES1—female gonad—uterine fibroid	0.00174	0.00249	CbGeAlD
Vandetanib—YES1—vagina—uterine fibroid	0.00173	0.00248	CbGeAlD
Vandetanib—STK10—female gonad—uterine fibroid	0.00172	0.00247	CbGeAlD
Vandetanib—STK10—vagina—uterine fibroid	0.00171	0.00246	CbGeAlD
Vandetanib—PDGFRB—mammalian vulva—uterine fibroid	0.00171	0.00245	CbGeAlD
Vandetanib—ABCC1—myometrium—uterine fibroid	0.00171	0.00244	CbGeAlD
Vandetanib—ABL1—smooth muscle tissue—uterine fibroid	0.00169	0.00243	CbGeAlD
Vandetanib—KDR—female reproductive system—uterine fibroid	0.00169	0.00243	CbGeAlD
Vandetanib—MAP2K5—female reproductive system—uterine fibroid	0.00169	0.00243	CbGeAlD
Vandetanib—SRC—female gonad—uterine fibroid	0.00167	0.0024	CbGeAlD
Vandetanib—ABL1—decidua—uterine fibroid	0.00166	0.00238	CbGeAlD
Vandetanib—ORM1—endometrium—uterine fibroid	0.00166	0.00238	CbGeAlD
Vandetanib—PDGFRB—cardiac atrium—uterine fibroid	0.00164	0.00235	CbGeAlD
Vandetanib—PDGFRB—uterus—uterine fibroid	0.00163	0.00233	CbGeAlD
Vandetanib—ABL1—urethra—uterine fibroid	0.0016	0.00229	CbGeAlD
Vandetanib—ABL1—endometrium—uterine fibroid	0.00158	0.00226	CbGeAlD
Vandetanib—MAP2K5—female gonad—uterine fibroid	0.00154	0.00221	CbGeAlD
Vandetanib—KDR—female gonad—uterine fibroid	0.00154	0.00221	CbGeAlD
Vandetanib—MAP2K5—vagina—uterine fibroid	0.00153	0.00219	CbGeAlD
Vandetanib—KDR—vagina—uterine fibroid	0.00153	0.00219	CbGeAlD
Vandetanib—ABL1—mammalian vulva—uterine fibroid	0.00153	0.00218	CbGeAlD
Vandetanib—EPHB6—Developmental Biology—MED12—uterine fibroid	0.0015	0.00496	CbGpPWpGaD
Vandetanib—FMO1—Metabolism—HPSE2—uterine fibroid	0.0015	0.00495	CbGpPWpGaD
Vandetanib—EGFR—GAB1 signalosome—TNRC6B—uterine fibroid	0.00149	0.00493	CbGpPWpGaD
Vandetanib—EGFR—Aryl Hydrocarbon Receptor—ESR1—uterine fibroid	0.00149	0.00493	CbGpPWpGaD
Vandetanib—LCK—PI-3K cascade—TNRC6B—uterine fibroid	0.00148	0.00491	CbGpPWpGaD
Vandetanib—PDGFRB—female reproductive system—uterine fibroid	0.00147	0.0021	CbGeAlD
Vandetanib—ABL1—cardiac atrium—uterine fibroid	0.00146	0.00209	CbGeAlD
Vandetanib—EGFR—Role of LAT2/NTAL/LAB on calcium mobilization—TNRC6B—uterine fibroid	0.00145	0.00482	CbGpPWpGaD
Vandetanib—ABL1—uterus—uterine fibroid	0.00145	0.00208	CbGeAlD
Vandetanib—LCK—PI3K/AKT activation—TNRC6B—uterine fibroid	0.00145	0.00479	CbGpPWpGaD
Vandetanib—LCK—GAB1 signalosome—TNRC6B—uterine fibroid	0.00143	0.00475	CbGpPWpGaD
Vandetanib—ABCG2—myometrium—uterine fibroid	0.00141	0.00202	CbGeAlD
Vandetanib—EPHA6—Developmental Biology—MED12—uterine fibroid	0.00141	0.00466	CbGpPWpGaD
Vandetanib—LCK—Role of LAT2/NTAL/LAB on calcium mobilization—TNRC6B—uterine fibroid	0.0014	0.00464	CbGpPWpGaD
Vandetanib—SRC—Plasma membrane estrogen receptor signaling—ESR1—uterine fibroid	0.00139	0.00461	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling by SCF-KIT—TNRC6B—uterine fibroid	0.00138	0.00457	CbGpPWpGaD
Vandetanib—ORM1—female reproductive system—uterine fibroid	0.00137	0.00197	CbGeAlD
Vandetanib—LYN—Signaling by SCF-KIT—TNRC6B—uterine fibroid	0.00135	0.00447	CbGpPWpGaD
Vandetanib—PDGFRB—female gonad—uterine fibroid	0.00133	0.00191	CbGeAlD
Vandetanib—FYN—Signaling by SCF-KIT—TNRC6B—uterine fibroid	0.00133	0.00441	CbGpPWpGaD
Vandetanib—RIPK2—Signaling by NGF—TNRC6B—uterine fibroid	0.00133	0.0044	CbGpPWpGaD
Vandetanib—ABCC1—uterine cervix—uterine fibroid	0.00133	0.0019	CbGeAlD
Vandetanib—PDGFRB—vagina—uterine fibroid	0.00133	0.0019	CbGeAlD
Vandetanib—PDGFRB—Downstream signaling of activated FGFR—TNRC6B—uterine fibroid	0.00132	0.00437	CbGpPWpGaD
Vandetanib—ABL1—female reproductive system—uterine fibroid	0.00131	0.00187	CbGeAlD
Vandetanib—PDGFRB—Signaling by ERBB4—TNRC6B—uterine fibroid	0.0013	0.0043	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling by ERBB4—PGR—uterine fibroid	0.00129	0.00426	CbGpPWpGaD
Vandetanib—ABL1—Regulation of Telomerase—ESR1—uterine fibroid	0.00127	0.00422	CbGpPWpGaD
Vandetanib—FYN—Downstream signaling of activated FGFR—TNRC6B—uterine fibroid	0.00127	0.00422	CbGpPWpGaD
Vandetanib—SRC—GAB1 signalosome—TNRC6B—uterine fibroid	0.00127	0.00421	CbGpPWpGaD
Vandetanib—SRC—Aryl Hydrocarbon Receptor—ESR1—uterine fibroid	0.00127	0.0042	CbGpPWpGaD
Vandetanib—ABCC1—decidua—uterine fibroid	0.00127	0.00181	CbGeAlD
Vandetanib—FYN—Signaling by ERBB4—TNRC6B—uterine fibroid	0.00125	0.00415	CbGpPWpGaD
Vandetanib—PDGFRB—Downstream signal transduction—TNRC6B—uterine fibroid	0.00124	0.00411	CbGpPWpGaD
Vandetanib—FYN—Signaling by ERBB4—PGR—uterine fibroid	0.00124	0.00411	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling by FGFR—TNRC6B—uterine fibroid	0.00123	0.00409	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling by ERBB2—TNRC6B—uterine fibroid	0.00123	0.00407	CbGpPWpGaD
Vandetanib—PDGFRB—DAP12 signaling—TNRC6B—uterine fibroid	0.00122	0.00405	CbGpPWpGaD
Vandetanib—ABCC1—urethra—uterine fibroid	0.00122	0.00175	CbGeAlD
Vandetanib—MAP2K5—Signaling by NGF—TNRC6B—uterine fibroid	0.00122	0.00403	CbGpPWpGaD
Vandetanib—PDGFRB—Downstream signaling events of B Cell Receptor (BCR)—TNRC6B—uterine fibroid	0.00121	0.00399	CbGpPWpGaD
Vandetanib—ABCC1—endometrium—uterine fibroid	0.0012	0.00172	CbGeAlD
Vandetanib—FYN—Downstream signal transduction—TNRC6B—uterine fibroid	0.0012	0.00396	CbGpPWpGaD
Vandetanib—FYN—Signaling by FGFR—TNRC6B—uterine fibroid	0.00119	0.00394	CbGpPWpGaD
Vandetanib—ABL1—female gonad—uterine fibroid	0.00119	0.0017	CbGeAlD
Vandetanib—FYN—Signaling by ERBB2—TNRC6B—uterine fibroid	0.00118	0.00392	CbGpPWpGaD
Vandetanib—ABL1—vagina—uterine fibroid	0.00118	0.00169	CbGeAlD
Vandetanib—FYN—DAP12 signaling—TNRC6B—uterine fibroid	0.00118	0.0039	CbGpPWpGaD
Vandetanib—ERBB3—Signaling by NGF—TNRC6B—uterine fibroid	0.00117	0.00388	CbGpPWpGaD
Vandetanib—FYN—Leptin signaling pathway—ESR1—uterine fibroid	0.00116	0.00386	CbGpPWpGaD
Vandetanib—FYN—Downstream signaling events of B Cell Receptor (BCR)—TNRC6B—uterine fibroid	0.00116	0.00385	CbGpPWpGaD
Vandetanib—ABCC1—mammalian vulva—uterine fibroid	0.00116	0.00166	CbGeAlD
Vandetanib—PDGFRB—Fc epsilon receptor (FCERI) signaling—TNRC6B—uterine fibroid	0.00115	0.00381	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling by FGFR in disease—TNRC6B—uterine fibroid	0.00115	0.00381	CbGpPWpGaD
Vandetanib—PDGFRB—DAP12 interactions—TNRC6B—uterine fibroid	0.00115	0.00381	CbGpPWpGaD
Vandetanib—EGFR—Signaling by SCF-KIT—TNRC6B—uterine fibroid	0.00115	0.00381	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling by EGFR—TNRC6B—uterine fibroid	0.00114	0.00378	CbGpPWpGaD
Vandetanib—VEGFA—Cellular responses to stress—TNRC6B—uterine fibroid	0.00114	0.00376	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling by EGFR in Cancer—TNRC6B—uterine fibroid	0.00113	0.00374	CbGpPWpGaD
Vandetanib—LYN—Fc epsilon receptor (FCERI) signaling—TNRC6B—uterine fibroid	0.00113	0.00373	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling by PDGF—TNRC6B—uterine fibroid	0.00113	0.00373	CbGpPWpGaD
Vandetanib—ABCC1—cardiac atrium—uterine fibroid	0.00111	0.00159	CbGeAlD
Vandetanib—FYN—DAP12 interactions—TNRC6B—uterine fibroid	0.00111	0.00367	CbGpPWpGaD
Vandetanib—FYN—Signaling by FGFR in disease—TNRC6B—uterine fibroid	0.00111	0.00367	CbGpPWpGaD
Vandetanib—FYN—Fc epsilon receptor (FCERI) signaling—TNRC6B—uterine fibroid	0.00111	0.00367	CbGpPWpGaD
Vandetanib—LCK—Signaling by SCF-KIT—TNRC6B—uterine fibroid	0.00111	0.00367	CbGpPWpGaD
Vandetanib—ABCC1—uterus—uterine fibroid	0.00111	0.00159	CbGeAlD
Vandetanib—EGFR—Downstream signaling of activated FGFR—TNRC6B—uterine fibroid	0.0011	0.00364	CbGpPWpGaD
Vandetanib—ABCG2—uterine cervix—uterine fibroid	0.0011	0.00157	CbGeAlD
Vandetanib—FYN—Signaling by EGFR—TNRC6B—uterine fibroid	0.0011	0.00364	CbGpPWpGaD
Vandetanib—FYN—Signaling by EGFR in Cancer—TNRC6B—uterine fibroid	0.00109	0.00361	CbGpPWpGaD
Vandetanib—EGFR—Regulation of Telomerase—ESR1—uterine fibroid	0.00109	0.00361	CbGpPWpGaD
Vandetanib—FYN—Signaling by PDGF—TNRC6B—uterine fibroid	0.00108	0.00359	CbGpPWpGaD
Vandetanib—EGFR—Signaling by ERBB4—TNRC6B—uterine fibroid	0.00108	0.00358	CbGpPWpGaD
Vandetanib—EGFR—Signaling by ERBB4—PGR—uterine fibroid	0.00107	0.00355	CbGpPWpGaD
Vandetanib—FMO3—Metabolism—HPSE2—uterine fibroid	0.00107	0.00354	CbGpPWpGaD
Vandetanib—PDGFRB—B Cell Activation—TNRC6B—uterine fibroid	0.00106	0.00353	CbGpPWpGaD
Vandetanib—LCK—Downstream signaling of activated FGFR—TNRC6B—uterine fibroid	0.00106	0.00351	CbGpPWpGaD
Vandetanib—ABCG2—decidua—uterine fibroid	0.00105	0.0015	CbGeAlD
Vandetanib—LCK—Signaling by ERBB4—TNRC6B—uterine fibroid	0.00104	0.00345	CbGpPWpGaD
Vandetanib—LYN—B Cell Activation—TNRC6B—uterine fibroid	0.00104	0.00345	CbGpPWpGaD
Vandetanib—EGFR—Downstream signal transduction—TNRC6B—uterine fibroid	0.00103	0.00342	CbGpPWpGaD
Vandetanib—LCK—Signaling by ERBB4—PGR—uterine fibroid	0.00103	0.00342	CbGpPWpGaD
Vandetanib—EGFR—Signaling by FGFR—TNRC6B—uterine fibroid	0.00103	0.00341	CbGpPWpGaD
Vandetanib—ERBB3—Signaling by ERBB4—ESR1—uterine fibroid	0.00103	0.0034	CbGpPWpGaD
Vandetanib—FYN—B Cell Activation—TNRC6B—uterine fibroid	0.00103	0.0034	CbGpPWpGaD
Vandetanib—EGFR—Signaling by ERBB2—TNRC6B—uterine fibroid	0.00102	0.00339	CbGpPWpGaD
Vandetanib—PDGFRB—NGF signalling via TRKA from the plasma membrane—TNRC6B—uterine fibroid	0.00102	0.00337	CbGpPWpGaD
Vandetanib—EGFR—DAP12 signaling—TNRC6B—uterine fibroid	0.00102	0.00337	CbGpPWpGaD
Vandetanib—ABCG2—urethra—uterine fibroid	0.00101	0.00145	CbGeAlD
Vandetanib—EGFR—Downstream signaling events of B Cell Receptor (BCR)—TNRC6B—uterine fibroid	0.001	0.00332	CbGpPWpGaD
Vandetanib—ERBB3—Disease—HPSE2—uterine fibroid	0.001	0.00332	CbGpPWpGaD
Vandetanib—LCK—Downstream signal transduction—TNRC6B—uterine fibroid	0.000996	0.0033	CbGpPWpGaD
Vandetanib—ABCG2—endometrium—uterine fibroid	0.000994	0.00142	CbGeAlD
Vandetanib—LCK—Signaling by FGFR—TNRC6B—uterine fibroid	0.000991	0.00328	CbGpPWpGaD
Vandetanib—LCK—Signaling by ERBB2—TNRC6B—uterine fibroid	0.000986	0.00327	CbGpPWpGaD
Vandetanib—FYN—NGF signalling via TRKA from the plasma membrane—TNRC6B—uterine fibroid	0.000982	0.00325	CbGpPWpGaD
Vandetanib—LCK—DAP12 signaling—TNRC6B—uterine fibroid	0.000981	0.00325	CbGpPWpGaD
Vandetanib—SRC—Signaling by SCF-KIT—TNRC6B—uterine fibroid	0.00098	0.00325	CbGpPWpGaD
Vandetanib—LCK—Downstream signaling events of B Cell Receptor (BCR)—TNRC6B—uterine fibroid	0.000967	0.0032	CbGpPWpGaD
Vandetanib—ABCG2—mammalian vulva—uterine fibroid	0.000962	0.00138	CbGeAlD
Vandetanib—EGFR—DAP12 interactions—TNRC6B—uterine fibroid	0.000958	0.00317	CbGpPWpGaD
Vandetanib—EGFR—Fc epsilon receptor (FCERI) signaling—TNRC6B—uterine fibroid	0.000958	0.00317	CbGpPWpGaD
Vandetanib—EGFR—Signaling by FGFR in disease—TNRC6B—uterine fibroid	0.000958	0.00317	CbGpPWpGaD
Vandetanib—EGFR—Signaling by EGFR—TNRC6B—uterine fibroid	0.000949	0.00314	CbGpPWpGaD
Vandetanib—EGFR—Signaling by EGFR in Cancer—TNRC6B—uterine fibroid	0.000941	0.00312	CbGpPWpGaD
Vandetanib—VEGFA—Integrated Breast Cancer Pathway—ESR1—uterine fibroid	0.000939	0.00311	CbGpPWpGaD
Vandetanib—EGFR—Signaling by PDGF—TNRC6B—uterine fibroid	0.000937	0.0031	CbGpPWpGaD
Vandetanib—LCK—Fc epsilon receptor (FCERI) signaling—TNRC6B—uterine fibroid	0.000923	0.00306	CbGpPWpGaD
Vandetanib—LCK—DAP12 interactions—TNRC6B—uterine fibroid	0.000923	0.00306	CbGpPWpGaD
Vandetanib—LCK—Signaling by FGFR in disease—TNRC6B—uterine fibroid	0.000923	0.00306	CbGpPWpGaD
Vandetanib—ABCG2—uterus—uterine fibroid	0.000916	0.00131	CbGeAlD
Vandetanib—LCK—Signaling by EGFR—TNRC6B—uterine fibroid	0.000915	0.00303	CbGpPWpGaD
Vandetanib—KDR—Developmental Biology—MED12—uterine fibroid	0.000914	0.00303	CbGpPWpGaD
Vandetanib—LCK—Signaling by EGFR in Cancer—TNRC6B—uterine fibroid	0.000907	0.003	CbGpPWpGaD
Vandetanib—ABCC1—female gonad—uterine fibroid	0.000905	0.0013	CbGeAlD
Vandetanib—LCK—Signaling by PDGF—TNRC6B—uterine fibroid	0.000903	0.00299	CbGpPWpGaD
Vandetanib—ABCC1—vagina—uterine fibroid	0.0009	0.00129	CbGeAlD
Vandetanib—EGFR—B Cell Activation—TNRC6B—uterine fibroid	0.000887	0.00294	CbGpPWpGaD
Vandetanib—SRC—Downstream signal transduction—TNRC6B—uterine fibroid	0.000882	0.00292	CbGpPWpGaD
Vandetanib—SRC—Signaling by FGFR—TNRC6B—uterine fibroid	0.000877	0.00291	CbGpPWpGaD
Vandetanib—SRC—Signaling by ERBB2—TNRC6B—uterine fibroid	0.000873	0.00289	CbGpPWpGaD
Vandetanib—SRC—Leptin signaling pathway—ESR1—uterine fibroid	0.000859	0.00284	CbGpPWpGaD
Vandetanib—LCK—B Cell Activation—TNRC6B—uterine fibroid	0.000854	0.00283	CbGpPWpGaD
Vandetanib—EGFR—NGF signalling via TRKA from the plasma membrane—TNRC6B—uterine fibroid	0.000848	0.00281	CbGpPWpGaD
Vandetanib—IRAK4—Innate Immune System—TNRC6B—uterine fibroid	0.000839	0.00278	CbGpPWpGaD
Vandetanib—VEGFA—Developmental Biology—MED12—uterine fibroid	0.000822	0.00272	CbGpPWpGaD
Vandetanib—LCK—NGF signalling via TRKA from the plasma membrane—TNRC6B—uterine fibroid	0.000818	0.00271	CbGpPWpGaD
Vandetanib—SRC—Signaling by FGFR in disease—TNRC6B—uterine fibroid	0.000817	0.00271	CbGpPWpGaD
Vandetanib—SRC—Signaling by EGFR—TNRC6B—uterine fibroid	0.00081	0.00268	CbGpPWpGaD
Vandetanib—SRC—Signaling by EGFR in Cancer—TNRC6B—uterine fibroid	0.000803	0.00266	CbGpPWpGaD
Vandetanib—SRC—Signaling by PDGF—TNRC6B—uterine fibroid	0.000799	0.00265	CbGpPWpGaD
Vandetanib—YES1—Developmental Biology—MED12—uterine fibroid	0.000794	0.00263	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling by NGF—TNRC6B—uterine fibroid	0.000784	0.0026	CbGpPWpGaD
Vandetanib—VEGFA—Integrated Pancreatic Cancer Pathway—ESR1—uterine fibroid	0.000778	0.00258	CbGpPWpGaD
Vandetanib—RIPK2—Innate Immune System—TNRC6B—uterine fibroid	0.000758	0.00251	CbGpPWpGaD
Vandetanib—FYN—Signaling by NGF—TNRC6B—uterine fibroid	0.000755	0.0025	CbGpPWpGaD
Vandetanib—ABCG2—female gonad—uterine fibroid	0.000749	0.00107	CbGeAlD
Vandetanib—ABCG2—vagina—uterine fibroid	0.000745	0.00107	CbGeAlD
Vandetanib—RIPK2—Adaptive Immune System—TNRC6B—uterine fibroid	0.000728	0.00241	CbGpPWpGaD
Vandetanib—FGR—Innate Immune System—TNRC6B—uterine fibroid	0.000727	0.00241	CbGpPWpGaD
Vandetanib—SRC—NGF signalling via TRKA from the plasma membrane—TNRC6B—uterine fibroid	0.000724	0.0024	CbGpPWpGaD
Vandetanib—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP17A1—uterine fibroid	0.000708	0.00234	CbGpPWpGaD
Vandetanib—BLK—Adaptive Immune System—TNRC6B—uterine fibroid	0.000701	0.00232	CbGpPWpGaD
Vandetanib—CYP3A4—Oxidation by Cytochrome P450—CYP17A1—uterine fibroid	0.000699	0.00231	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling by ERBB4—ESR1—uterine fibroid	0.000687	0.00227	CbGpPWpGaD
Vandetanib—ABL1—Integrated Breast Cancer Pathway—ESR1—uterine fibroid	0.000673	0.00223	CbGpPWpGaD
Vandetanib—PDGFRB—Disease—HPSE2—uterine fibroid	0.000671	0.00222	CbGpPWpGaD
Vandetanib—ERBB3—Innate Immune System—TNRC6B—uterine fibroid	0.000669	0.00221	CbGpPWpGaD
Vandetanib—FYN—Signaling by ERBB4—ESR1—uterine fibroid	0.000662	0.00219	CbGpPWpGaD
Vandetanib—EGFR—Signaling by NGF—TNRC6B—uterine fibroid	0.000653	0.00216	CbGpPWpGaD
Vandetanib—FYN—Disease—HPSE2—uterine fibroid	0.000646	0.00214	CbGpPWpGaD
Vandetanib—ERBB3—Adaptive Immune System—TNRC6B—uterine fibroid	0.000642	0.00213	CbGpPWpGaD
Vandetanib—FMO1—Metabolism—MED12—uterine fibroid	0.00064	0.00212	CbGpPWpGaD
Vandetanib—LCK—Signaling by NGF—TNRC6B—uterine fibroid	0.000629	0.00208	CbGpPWpGaD
Vandetanib—AXL—Signaling Pathways—TNRC6B—uterine fibroid	0.000613	0.00203	CbGpPWpGaD
Vandetanib—AXL—Signaling Pathways—PGR—uterine fibroid	0.000607	0.00201	CbGpPWpGaD
Vandetanib—MKNK1—Disease—TNRC6B—uterine fibroid	0.000607	0.00201	CbGpPWpGaD
Vandetanib—ABCC1—Disease—HPSE2—uterine fibroid	0.000592	0.00196	CbGpPWpGaD
Vandetanib—LYN—Developmental Biology—MED12—uterine fibroid	0.000592	0.00196	CbGpPWpGaD
Vandetanib—ABL1—Developmental Biology—MED12—uterine fibroid	0.000589	0.00195	CbGpPWpGaD
Vandetanib—YES1—Innate Immune System—TNRC6B—uterine fibroid	0.000587	0.00194	CbGpPWpGaD
Vandetanib—FYN—Developmental Biology—MED12—uterine fibroid	0.000583	0.00193	CbGpPWpGaD
Vandetanib—EGFR—Integrated Breast Cancer Pathway—ESR1—uterine fibroid	0.000575	0.0019	CbGpPWpGaD
Vandetanib—CYP3A4—Phase 1 - Functionalization of compounds—CYP17A1—uterine fibroid	0.000574	0.0019	CbGpPWpGaD
Vandetanib—CYP3A4—female reproductive system—uterine fibroid	0.000574	0.000822	CbGeAlD
Vandetanib—EGFR—Signaling by ERBB4—ESR1—uterine fibroid	0.000572	0.00189	CbGpPWpGaD
Vandetanib—YES1—Adaptive Immune System—TNRC6B—uterine fibroid	0.000564	0.00187	CbGpPWpGaD
Vandetanib—BMPR1B—Signaling Pathways—TNRC6B—uterine fibroid	0.000561	0.00186	CbGpPWpGaD
Vandetanib—EGFR—Disease—HPSE2—uterine fibroid	0.000558	0.00185	CbGpPWpGaD
Vandetanib—ABL1—Integrated Pancreatic Cancer Pathway—ESR1—uterine fibroid	0.000558	0.00185	CbGpPWpGaD
Vandetanib—SRC—Signaling by NGF—TNRC6B—uterine fibroid	0.000557	0.00184	CbGpPWpGaD
Vandetanib—BMPR1B—Signaling Pathways—PGR—uterine fibroid	0.000555	0.00184	CbGpPWpGaD
Vandetanib—LCK—Signaling by ERBB4—ESR1—uterine fibroid	0.000551	0.00183	CbGpPWpGaD
Vandetanib—LCK—Disease—HPSE2—uterine fibroid	0.000538	0.00178	CbGpPWpGaD
Vandetanib—FMO1—Metabolism—CYP17A1—uterine fibroid	0.000536	0.00178	CbGpPWpGaD
Vandetanib—FLT4—Signaling Pathways—TNRC6B—uterine fibroid	0.000513	0.0017	CbGpPWpGaD
Vandetanib—FLT4—Signaling Pathways—PGR—uterine fibroid	0.000508	0.00168	CbGpPWpGaD
Vandetanib—EGFR—Developmental Biology—MED12—uterine fibroid	0.000504	0.00167	CbGpPWpGaD
Vandetanib—ABCC1—Metabolism—HPSE2—uterine fibroid	0.000496	0.00164	CbGpPWpGaD
Vandetanib—IRAK4—Immune System—TNRC6B—uterine fibroid	0.000488	0.00162	CbGpPWpGaD
Vandetanib—ABCC1—Metabolism of lipids and lipoproteins—MED12—uterine fibroid	0.000477	0.00158	CbGpPWpGaD
Vandetanib—EGFR—Integrated Pancreatic Cancer Pathway—ESR1—uterine fibroid	0.000476	0.00158	CbGpPWpGaD
Vandetanib—SRC—Disease—HPSE2—uterine fibroid	0.000476	0.00158	CbGpPWpGaD
Vandetanib—FMO3—Metabolism—MED12—uterine fibroid	0.000458	0.00152	CbGpPWpGaD
Vandetanib—PDGFRB—Innate Immune System—TNRC6B—uterine fibroid	0.000447	0.00148	CbGpPWpGaD
Vandetanib—RIPK2—Immune System—TNRC6B—uterine fibroid	0.000442	0.00146	CbGpPWpGaD
Vandetanib—LYN—Innate Immune System—TNRC6B—uterine fibroid	0.000438	0.00145	CbGpPWpGaD
Vandetanib—ABCG2—Metabolism—HPSE2—uterine fibroid	0.000437	0.00145	CbGpPWpGaD
Vandetanib—ABL1—Innate Immune System—TNRC6B—uterine fibroid	0.000436	0.00144	CbGpPWpGaD
Vandetanib—FYN—Innate Immune System—TNRC6B—uterine fibroid	0.000431	0.00143	CbGpPWpGaD
Vandetanib—SRC—Developmental Biology—MED12—uterine fibroid	0.00043	0.00142	CbGpPWpGaD
Vandetanib—PDGFRB—Adaptive Immune System—TNRC6B—uterine fibroid	0.000429	0.00142	CbGpPWpGaD
Vandetanib—BLK—Immune System—TNRC6B—uterine fibroid	0.000425	0.00141	CbGpPWpGaD
Vandetanib—MKNK1—Signaling Pathways—TNRC6B—uterine fibroid	0.000425	0.00141	CbGpPWpGaD
Vandetanib—FGR—Immune System—TNRC6B—uterine fibroid	0.000423	0.0014	CbGpPWpGaD
Vandetanib—MKNK1—Signaling Pathways—PGR—uterine fibroid	0.000421	0.00139	CbGpPWpGaD
Vandetanib—LYN—Adaptive Immune System—TNRC6B—uterine fibroid	0.00042	0.00139	CbGpPWpGaD
Vandetanib—FYN—Adaptive Immune System—TNRC6B—uterine fibroid	0.000414	0.00137	CbGpPWpGaD
Vandetanib—SRC—Integrated Pancreatic Cancer Pathway—ESR1—uterine fibroid	0.000406	0.00135	CbGpPWpGaD
Vandetanib—ABCC1—Metabolism of lipids and lipoproteins—CYP17A1—uterine fibroid	0.000399	0.00132	CbGpPWpGaD
Vandetanib—ERBB3—Immune System—TNRC6B—uterine fibroid	0.000389	0.00129	CbGpPWpGaD
Vandetanib—FMO3—Metabolism—CYP17A1—uterine fibroid	0.000383	0.00127	CbGpPWpGaD
Vandetanib—EGFR—Innate Immune System—TNRC6B—uterine fibroid	0.000372	0.00123	CbGpPWpGaD
Vandetanib—ERBB3—Disease—TNRC6B—uterine fibroid	0.00036	0.00119	CbGpPWpGaD
Vandetanib—LCK—Innate Immune System—TNRC6B—uterine fibroid	0.000359	0.00119	CbGpPWpGaD
Vandetanib—EGFR—Adaptive Immune System—TNRC6B—uterine fibroid	0.000357	0.00118	CbGpPWpGaD
Vandetanib—LCK—Adaptive Immune System—TNRC6B—uterine fibroid	0.000344	0.00114	CbGpPWpGaD
Vandetanib—YES1—Immune System—TNRC6B—uterine fibroid	0.000342	0.00113	CbGpPWpGaD
Vandetanib—AXL—Signaling Pathways—ESR1—uterine fibroid	0.000324	0.00107	CbGpPWpGaD
Vandetanib—SRC—Innate Immune System—TNRC6B—uterine fibroid	0.000318	0.00105	CbGpPWpGaD
Vandetanib—SRC—Adaptive Immune System—TNRC6B—uterine fibroid	0.000305	0.00101	CbGpPWpGaD
Vandetanib—CYP3A4—Biological oxidations—CYP17A1—uterine fibroid	0.000305	0.00101	CbGpPWpGaD
Vandetanib—CYP3A4—Metapathway biotransformation—CYP17A1—uterine fibroid	0.000301	0.000996	CbGpPWpGaD
Vandetanib—BMPR1B—Signaling Pathways—ESR1—uterine fibroid	0.000296	0.000982	CbGpPWpGaD
Vandetanib—RIPK2—Signaling Pathways—TNRC6B—uterine fibroid	0.000286	0.000946	CbGpPWpGaD
Vandetanib—RIPK2—Signaling Pathways—PGR—uterine fibroid	0.000283	0.000936	CbGpPWpGaD
Vandetanib—FLT4—Signaling Pathways—ESR1—uterine fibroid	0.000271	0.000898	CbGpPWpGaD
Vandetanib—ALB—Metabolism—HPSE2—uterine fibroid	0.000269	0.000892	CbGpPWpGaD
Vandetanib—MAP2K5—Signaling Pathways—TNRC6B—uterine fibroid	0.000261	0.000865	CbGpPWpGaD
Vandetanib—PDGFRB—Immune System—TNRC6B—uterine fibroid	0.00026	0.000862	CbGpPWpGaD
Vandetanib—ALB—Metabolism of lipids and lipoproteins—MED12—uterine fibroid	0.000259	0.000858	CbGpPWpGaD
Vandetanib—MAP2K5—Signaling Pathways—PGR—uterine fibroid	0.000259	0.000856	CbGpPWpGaD
Vandetanib—LYN—Immune System—TNRC6B—uterine fibroid	0.000255	0.000844	CbGpPWpGaD
Vandetanib—KDR—Signaling Pathways—TNRC6B—uterine fibroid	0.000255	0.000843	CbGpPWpGaD
Vandetanib—ABL1—Immune System—TNRC6B—uterine fibroid	0.000254	0.00084	CbGpPWpGaD
Vandetanib—KDR—Signaling Pathways—PGR—uterine fibroid	0.000252	0.000835	CbGpPWpGaD
Vandetanib—ERBB3—Signaling Pathways—TNRC6B—uterine fibroid	0.000252	0.000834	CbGpPWpGaD
Vandetanib—FYN—Immune System—TNRC6B—uterine fibroid	0.000251	0.000831	CbGpPWpGaD
Vandetanib—ERBB3—Signaling Pathways—PGR—uterine fibroid	0.000249	0.000826	CbGpPWpGaD
Vandetanib—PDGFRB—Disease—TNRC6B—uterine fibroid	0.00024	0.000796	CbGpPWpGaD
Vandetanib—FYN—Disease—TNRC6B—uterine fibroid	0.000232	0.000767	CbGpPWpGaD
Vandetanib—VEGFA—Signaling Pathways—TNRC6B—uterine fibroid	0.000229	0.000758	CbGpPWpGaD
Vandetanib—VEGFA—Signaling Pathways—PGR—uterine fibroid	0.000226	0.00075	CbGpPWpGaD
Vandetanib—MKNK1—Signaling Pathways—ESR1—uterine fibroid	0.000225	0.000744	CbGpPWpGaD
Vandetanib—YES1—Signaling Pathways—TNRC6B—uterine fibroid	0.000221	0.000732	CbGpPWpGaD
Vandetanib—YES1—Signaling Pathways—PGR—uterine fibroid	0.000219	0.000725	CbGpPWpGaD
Vandetanib—ALB—Metabolism of lipids and lipoproteins—CYP17A1—uterine fibroid	0.000217	0.000718	CbGpPWpGaD
Vandetanib—EGFR—Immune System—TNRC6B—uterine fibroid	0.000217	0.000718	CbGpPWpGaD
Vandetanib—ABCC1—Metabolism—MED12—uterine fibroid	0.000212	0.000704	CbGpPWpGaD
Vandetanib—ABCC1—Disease—TNRC6B—uterine fibroid	0.000212	0.000703	CbGpPWpGaD
Vandetanib—LCK—Immune System—TNRC6B—uterine fibroid	0.000209	0.000692	CbGpPWpGaD
Vandetanib—EGFR—Disease—TNRC6B—uterine fibroid	0.0002	0.000663	CbGpPWpGaD
Vandetanib—LCK—Disease—TNRC6B—uterine fibroid	0.000193	0.000639	CbGpPWpGaD
Vandetanib—ABCG2—Metabolism—MED12—uterine fibroid	0.000187	0.000619	CbGpPWpGaD
Vandetanib—SRC—Immune System—TNRC6B—uterine fibroid	0.000185	0.000613	CbGpPWpGaD
Vandetanib—ABCC1—Metabolism—CYP17A1—uterine fibroid	0.000178	0.000589	CbGpPWpGaD
Vandetanib—SRC—Disease—TNRC6B—uterine fibroid	0.000171	0.000566	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling Pathways—TNRC6B—uterine fibroid	0.000168	0.000557	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling Pathways—PGR—uterine fibroid	0.000167	0.000552	CbGpPWpGaD
Vandetanib—LYN—Signaling Pathways—TNRC6B—uterine fibroid	0.000165	0.000546	CbGpPWpGaD
Vandetanib—LYN—Signaling Pathways—PGR—uterine fibroid	0.000163	0.00054	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—TNRC6B—uterine fibroid	0.000162	0.000537	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—PGR—uterine fibroid	0.000161	0.000532	CbGpPWpGaD
Vandetanib—ABCG2—Metabolism—CYP17A1—uterine fibroid	0.000156	0.000518	CbGpPWpGaD
Vandetanib—RIPK2—Signaling Pathways—ESR1—uterine fibroid	0.000151	0.0005	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—HPSE2—uterine fibroid	0.000145	0.000482	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—TNRC6B—uterine fibroid	0.00014	0.000464	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—PGR—uterine fibroid	0.000139	0.00046	CbGpPWpGaD
Vandetanib—MAP2K5—Signaling Pathways—ESR1—uterine fibroid	0.000138	0.000457	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—TNRC6B—uterine fibroid	0.000135	0.000447	CbGpPWpGaD
Vandetanib—KDR—Signaling Pathways—ESR1—uterine fibroid	0.000135	0.000446	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—PGR—uterine fibroid	0.000134	0.000443	CbGpPWpGaD
Vandetanib—ERBB3—Signaling Pathways—ESR1—uterine fibroid	0.000133	0.000441	CbGpPWpGaD
Vandetanib—VEGFA—Signaling Pathways—ESR1—uterine fibroid	0.000121	0.000401	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—TNRC6B—uterine fibroid	0.00012	0.000396	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—PGR—uterine fibroid	0.000118	0.000392	CbGpPWpGaD
Vandetanib—YES1—Signaling Pathways—ESR1—uterine fibroid	0.000117	0.000387	CbGpPWpGaD
Vandetanib—ALB—Metabolism—MED12—uterine fibroid	0.000115	0.000382	CbGpPWpGaD
Vandetanib—ALB—Metabolism—CYP17A1—uterine fibroid	9.66e-05	0.00032	CbGpPWpGaD
Vandetanib—PDGFRB—Signaling Pathways—ESR1—uterine fibroid	8.9e-05	0.000295	CbGpPWpGaD
Vandetanib—LYN—Signaling Pathways—ESR1—uterine fibroid	8.71e-05	0.000289	CbGpPWpGaD
Vandetanib—FYN—Signaling Pathways—ESR1—uterine fibroid	8.58e-05	0.000284	CbGpPWpGaD
Vandetanib—EGFR—Signaling Pathways—ESR1—uterine fibroid	7.41e-05	0.000245	CbGpPWpGaD
Vandetanib—LCK—Signaling Pathways—ESR1—uterine fibroid	7.14e-05	0.000236	CbGpPWpGaD
Vandetanib—SRC—Signaling Pathways—ESR1—uterine fibroid	6.32e-05	0.000209	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—MED12—uterine fibroid	6.23e-05	0.000206	CbGpPWpGaD
Vandetanib—CYP3A4—Metabolism—CYP17A1—uterine fibroid	5.21e-05	0.000173	CbGpPWpGaD
